1. Home
  2. GGG vs SNN Comparison

GGG vs SNN Comparison

Compare GGG & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Graco Inc.

GGG

Graco Inc.

HOLD

Current Price

$84.49

Market Cap

14.3B

Sector

Industrials

ML Signal

HOLD

Logo Smith & Nephew SNATS Inc.

SNN

Smith & Nephew SNATS Inc.

HOLD

Current Price

$32.59

Market Cap

14.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GGG
SNN
Founded
1926
1856
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Fluid Controls
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.3B
14.3B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
GGG
SNN
Price
$84.49
$32.59
Analyst Decision
Buy
Hold
Analyst Count
4
2
Target Price
$95.25
$36.25
AVG Volume (30 Days)
926.8K
628.0K
Earning Date
04-22-2026
04-30-2026
Dividend Yield
1.39%
2.34%
EPS Growth
9.22
N/A
EPS
3.08
N/A
Revenue
$2,236,604,000.00
N/A
Revenue This Year
$6.81
$8.61
Revenue Next Year
$4.65
$5.60
P/E Ratio
$27.47
$64.97
Revenue Growth
5.83
N/A
52 Week Low
$72.29
$23.91
52 Week High
$95.69
$38.79

Technical Indicators

Market Signals
Indicator
GGG
SNN
Relative Strength Index (RSI) 40.88 45.33
Support Level $83.38 $32.15
Resistance Level $87.94 $32.61
Average True Range (ATR) 1.76 0.54
MACD 0.06 0.05
Stochastic Oscillator 39.73 60.17

Price Performance

Historical Comparison
GGG
SNN

About GGG Graco Inc.

Graco manufactures equipment used for managing fluids, coatings, and adhesives, specializing in difficult-to-handle materials. Graco's business is organized into three segments: industrial, process, and contractor. The Minnesota-based firm serves a wide range of end markets, including industrial, automotive, and construction, and its broad array of products include pumps, valves, meters, sprayers, and equipment used to apply coatings, sealants, and adhesives. The firm generated roughly $2.2 billion in sales in 2025.

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Share on Social Networks: